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Abstract
Background: Malaria is a very important cause of anaemia in tropical countries. Anaemia is
assessed either by measurement of the haematocrit or the haemoglobin concentration. For
comparisons across studies, it is often necessary to derive one measure from the other.
Methods: Data on patients with slide-confirmed uncomplicated falciparum malaria were pooled
from 85 antimalarial drug trials conducted in 25 different countries, to assess the haemoglobin/
haematocrit relationship at different time points in malaria. Using a linear random effects model, a
conversion equation for haematocrit was derived based on 3,254 measurements from various time
points (ranging from day 0 to day 63) from 1,810 patients with simultaneous measurements of both
parameters. Haemoglobin was also estimated from haematocrit with the commonly used threefold
conversion.
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Results: A good fit was obtained using Haematocrit = 5.62 + 2.60 * Haemoglobin. On average,
haematocrit/3 levels were slightly higher than haemoglobin measurements with a mean difference
(± SD) of -0.69 (± 1.3) for children under the age of 5 (n = 1,440 measurements from 449 patients).
Conclusion: Based on this large data set, an accurate and robust conversion factor both in acute
malaria and in convalescence was obtained. The commonly used threefold conversion is also valid.
Background
Malaria is a major cause of anaemia in tropical countries.
It results from the obligatory destruction of parasitized
erythrocytes, the accelerated destruction of normal eryth-
rocytes, and variable dyserythropoiesis. Anaemia is
assessed either by measurement of the haematocrit or the
haemoglobin concentration. Clinical and epidemiologi-
cal studies of malaria use either measure, so for compari-
sons across studies, it is often necessary to derive one
measure from the other. Malaria is associated with
increased acute phase protein concentrations and severe
malaria increases erythrocyte rigidity, which may affect
the relationship between haemoglobin and haematocrit.
Recently, it has been suggested that the threefold conver-
sion that is commonly used to equate the two measures
(haemoglobin = haematocrit/3), consistently overesti-
mates the haemoglobin concentration resulting in an
underestimate of the prevalence of anaemia [1,2].
This is important as anaemia is an important measure
both of the efficacy of antimalarial treatment and the
effectiveness of malaria control programmes. Data from
patients with slide-confirmed, uncomplicated falciparum
malaria were pooled from 85 antimalarial drug trials con-
ducted in 25 different countries, to assess the haemo-
globin/haematocrit relationship at different time points
in malaria.
Methods
There were 78,239 haematocrit (Ht) measurements from
17,739 patients compared with 26,863 haemoglobin
(Hb) measurements from 13,092 patients. The conver-
sion equation for haematocrit was based on 3,254 meas-
urements from various timepoints from 1,810 patients
with simultaneous measurements of both parameters
(mean Hb 10.5 g/dl, standard deviation (SD) 2.5 g/dl;
mean Ht 33.0%, SD 7.1%). Post-treatment follow-up
ranged from 14 to 63 days. Haematocrit was measured by
centrifugation for 673 patients and by conductivity for
1,137 patients.
Because haematocrit or haemoglobin concentrations
change during recovery from malaria, adjustment for time
was included. The potential effect of age and sex on the
haematocrit/haemoglobin relationship was also explored.
a) Plot of observed versus predicted haematocrit measurements with a line to depict the relationship with the actual haemat- ocrit values, b) Bland-Altman plot of agreement between actual haematocrit measurements and haematocrit values estimated  from haemoglobin measurements Figure 1
a) Plot of observed versus predicted haematocrit measurements with a line to depict the relationship with the 
actual haematocrit values, b) Bland-Altman plot of agreement between actual haematocrit measurements 
and haematocrit values estimated from haemoglobin measurements.
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Bland-Altman plots of agreement between actual haemoglobin measurements and haemoglobin values estimated from haemat- ocrit measurements, by age group (Note: age was missing for seven patients) Figure 2
Bland-Altman plots of agreement between actual haemoglobin measurements and haemoglobin values esti-
mated from haematocrit measurements, by age group (Note: age was missing for seven patients).
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Results and discussion
As there was significant random variation within each
individual as well as between individuals (Breusch and
Pagan Lagrange multiplier test for random effects, p <
0.0001) [3] a linear random effects model was con-
structed using the equation:
Htit = α + Hbit * βhb + time * βtime + vi + eit (1)
(where Ht is haematocrit (%), Hb is haemoglobin (g/dL),
vi is the random effect for each individual, i, β is the coef-
ficient for each parameter that the model estimated, eit is
the deviation for each individual, i, at time, t, and α is the
intercept) and obtained: Ht = 5.66 + 2.58 * Hb + 0.01 *
time which explained approximately 80% of the variance
in the model (r2 (within) = 0.63, r2 (between) = 0.82, r2
(overall) = 0.83). Age and sex did not significantly
improve the model fit (p = 0.22 and p = 0.17, respec-
tively).
Although time contributed significantly to the model fit
(95% CI 0.005, 0.023), its effect was very small. For exam-
ple, a haematocrit value of 35.5% at day 0 would change
to 35.78% (35.5 + 0.28) on day 28 if time were taken into
account.
A simpified conversion without the time covariate using a
random effects model gave:
Ht = 5.62 + 2.60 * Hb (2)
The model fit was still good (r2  (within) = 0.63, r2
(between) = 0.82, r2 (overall) = 0.82; Figure 1a).
Using a Bland -Altman plot [4] to compare the values
obtained using the conversion equation with the original
observed values, the mean difference was -0.019 (95% CI
-0.12 to 0.09) percentage points indicating that, overall,
the predictions from the conversion equation tended to
give slightly lower haematocrit estimates by up to 0.12
percentage points (Figure 1b). However, the conversion
equation also overestimated haematocrit by up to 0.23
percentage points. Limits of agreement were calculated as
the mean difference ± 1.96 SD and 94.3% of the values fell
within these limits.
Comparing these results with those reported by Carneiro
et al, haemoglobin was also estimated from haematocrit
with the commonly used threefold conversion using data
from children under the age of five only (n = 1,440 meas-
urements from 449 patients). The Bland-Altman plot
showed good agreement when comparing haemoglobin
in the field and values estimated using the threefold con-
version. On average, haematocrit/3 levels were slightly
higher than haemoglobin measurements with a mean dif-
ference (± SD; 95% CI) of -0.69 (± 1.3; -0.75 to -0.62).
74.2% of haematocrit/3 levels were higher than haemo-
globin measurements. In contrast to Carneiro et al, but
similar to Rodriguez-Morales et al, larger negative differ-
ences were not observed with decreasing haemoglobin
levels (Figure 2a). Agreement was also good when apply-
ing the threefold conversion to measurements from
patients between five and 14 years of age (n = 501 meas-
urements from 216 patients, Figure 2b), but was best
when used in adults (15 years and older, n = 1,306 meas-
urements from 376 patients, Figure 2c).
Conclusion
In summary, based on this large data set, the conversion
factor to equate haemoglobin and haematocrit (Ht = 5.62
+ 2.60 * Hb) is accurate and robust both in acute uncom-
plicated malaria and in convalescence. The two measures
can be readily interconverted. The commonly used three-
fold conversion is also valid.
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